Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    June 2022
  1. CUSIMANO GM, Gary EN, Bell MR, Warner BM, et al
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
    PubMed     Abstract available


  2. NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
    The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
    J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
    PubMed     Abstract available


  3. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    PubMed     Abstract available


  4. KRMESKA V, Aggio JB, Nylen S, Wowk PF, et al
    Cyclooxygenase-Derived Prostaglandin E2 Drives IL-1-Independent Mycobacterium bovis Bacille Calmette-Guerin-Triggered Skin Dendritic Cell Migration to Draining Lymph Node.
    J Immunol. 2022;208:2549-2557.
    PubMed     Abstract available


    May 2022
  5. RICHERT L, Lelievre JD, Lacabaratz C, Hardel L, et al
    T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.
    J Immunol. 2022 May 25. pii: jimmunol.2101076. doi: 10.4049/jimmunol.2101076.
    PubMed     Abstract available


    April 2022
  6. SOMIYA M
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2022;208:1833.
    PubMed    


  7. BANSAL S, Fleming T, Mohanakumar T
    Response to Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2022;208:1833-1834.
    PubMed    


    March 2022
  8. DHUME K, Finn CM, Devarajan P, Singh A, et al
    Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
    J Immunol. 2022 Mar 25. pii: jimmunol.2100801. doi: 10.4049/jimmunol.2100801.
    PubMed     Abstract available


  9. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    PubMed     Abstract available


  10. ROBERTS LM, Wehrly TD, Leighton I, Hanley P, et al
    Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent Francisella tularensis.
    J Immunol. 2022;208:1180-1188.
    PubMed     Abstract available


    February 2022
  11. KOHN EM, Dos Santos Dias L, Dobson HE, He X, et al
    SLAMF1 Is Dispensable for Vaccine-Induced T Cell Development but Required for Resistance to Fungal Infection.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100819. doi: 10.4049/jimmunol.2100819.
    PubMed     Abstract available


  12. QIN Y, Teng Q, Feng D, Pei Y, et al
    Development of a Nanoparticle Multiepitope DNA Vaccine against Virulent Infectious Bronchitis Virus Challenge.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100909. doi: 10.4049/jimmunol.2100909.
    PubMed     Abstract available


  13. SHAH JA, Warr AJ, Graustein AD, Saha A, et al
    REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100671. doi: 10.4049/jimmunol.2100671.
    PubMed     Abstract available


  14. DWIVEDI V, Gautam S, Headley CA, Piergallini T, et al
    IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette-Guerin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice.
    J Immunol. 2022 Feb 18. pii: jimmunol.2100900. doi: 10.4049/jimmunol.2100900.
    PubMed     Abstract available


  15. MEYER-ARNDT L, Schwarz T, Loyal L, Henze L, et al
    Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4(+) T Cells following BNT162b2 Vaccination in the Elderly.
    J Immunol. 2022 Feb 4. pii: jimmunol.2100990. doi: 10.4049/jimmunol.2100990.
    PubMed     Abstract available


  16. NICOLI F, Cabral-Piccin MP, Papagno L, Gallerani E, et al
    Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8(+) T Cells in Elderly Humans.
    J Immunol. 2022;208:562-570.
    PubMed     Abstract available


    January 2022
  17. KOMISSAROV AA, Dolzhikova IV, Efimov GA, Logunov DY, et al
    Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
    J Immunol. 2022 Jan 31. pii: jimmunol.2101052. doi: 10.4049/jimmunol.2101052.
    PubMed     Abstract available


  18. TU MK, Chiang SH, Bender RA, Wong DTW, et al
    The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100919. doi: 10.4049/jimmunol.2100919.
    PubMed     Abstract available


    December 2021
  19. JONG RM, Van Dis E, Berry SB, Nguyenla X, et al
    Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.
    J Immunol. 2021 Dec 29. pii: jimmunol.2100029. doi: 10.4049/jimmunol.2100029.
    PubMed     Abstract available


    November 2021
  20. HINKLE L, Liu Y, Meng C, Chen Z, et al
    The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.
    J Immunol. 2021 Nov 12. pii: jimmunol.2100719. doi: 10.4049/jimmunol.2100719.
    PubMed     Abstract available


  21. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    PubMed     Abstract available


    October 2021
  22. LEFEBVRE MN, Drewry LL, Pewe LL, Hancox LS, et al
    Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites.
    J Immunol. 2021 Oct 29. pii: jimmunol.2100818. doi: 10.4049/jimmunol.2100818.
    PubMed     Abstract available


  23. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    PubMed     Abstract available


  24. SPURRIER MA, Jennings-Gee JE, Daly CA, Haas KM, et al
    The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.
    J Immunol. 2021;207:1978-1989.
    PubMed     Abstract available


    August 2021
  25. OCHSNER SP, Li W, Rajendrakumar AM, Palaniyandi S, et al
    FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100297. doi: 10.4049/jimmunol.2100297.
    PubMed     Abstract available


  26. ARANHA MP, Penfound TA, Salehi S, Botteaux A, et al
    Design of Broadly Cross-Reactive M Protein-Based Group A Streptococcal Vaccines.
    J Immunol. 2021 Aug 2. pii: jimmunol.2100286. doi: 10.4049/jimmunol.2100286.
    PubMed     Abstract available


  27. BAYARRI-OLMOS R, Idorn M, Rosbjerg A, Perez-Alos L, et al
    SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
    J Immunol. 2021;207:878-887.
    PubMed     Abstract available


    July 2021
  28. SANDBERG JT, Ols S, Lofling M, Varnaite R, et al
    Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
    J Immunol. 2021 Jul 28. pii: jimmunol.2001381. doi: 10.4049/jimmunol.2001381.
    PubMed     Abstract available


  29. HUSEBY KELCHER AM, Baehr CA, Hamid FA, Hart GT, et al
    Contribution of Antibody-Mediated Effector Functions to the Mechanism of Efficacy of Vaccines for Opioid Use Disorders.
    J Immunol. 2021 Jul 19. pii: jimmunol.2100204. doi: 10.4049/jimmunol.2100204.
    PubMed     Abstract available


  30. COLE LE, Elkins KL, Michalek SM, Qureshi N, et al
    Correction: Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity.
    J Immunol. 2021 Jul 16. pii: jimmunol.2100505. doi: 10.4049/jimmunol.2100505.
    PubMed    


  31. BARBER-AXTHELM IM, Kelly HG, Esterbauer R, Wragg KM, et al
    Coformulation with Tattoo Ink for Immunological Assessment of Vaccine Immunogenicity in the Draining Lymph Node.
    J Immunol. 2021 Jul 9. pii: jimmunol.2001299. doi: 10.4049/jimmunol.2001299.
    PubMed     Abstract available


    June 2021
  32. MATCHETT WE, Joag V, Stolley JM, Shepherd FK, et al
    Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.
    J Immunol. 2021 Jun 30. pii: jimmunol.2100421. doi: 10.4049/jimmunol.2100421.
    PubMed     Abstract available


  33. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Correction: Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2021 Jun 18. pii: jimmunol.2100261. doi: 10.4049/jimmunol.2100261.
    PubMed    


  34. SANDOR AM, Sturdivant MS, Ting JPY
    Influenza Virus and SARS-CoV-2 Vaccines.
    J Immunol. 2021;206:2509-2520.
    PubMed     Abstract available


    May 2021
  35. HARBOUR JC, Lyski ZL, Schell JB, Thomas A, et al
    Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein.
    J Immunol. 2021 May 10. pii: jimmunol.2100054. doi: 10.4049/jimmunol.2100054.
    PubMed     Abstract available


  36. DAVENPORT BJ, Morrison TE, Kedl RM, Klarquist J, et al
    Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination.
    J Immunol. 2021 May 10. pii: jimmunol.2100195. doi: 10.4049/jimmunol.2100195.
    PubMed     Abstract available


  37. MANSOURI S, Katikaneni DS, Gogoi H, Jin L, et al
    Monocyte-Derived Dendritic Cells (moDCs) Differentiate into Bcl6(+) Mature moDCs to Promote Cyclic di-GMP Vaccine Adjuvant-Induced Memory TH Cells in the Lung.
    J Immunol. 2021;206:2233-2245.
    PubMed     Abstract available


  38. STEPHENS LM, Ross KA, Waldstein KA, Legge KL, et al
    Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.
    J Immunol. 2021;206:2122-2134.
    PubMed     Abstract available


    April 2021
  39. JHA V, Nicholson LK, Gardner EM, Rahkola JT, et al
    Impact of HIV-1 Infection and Antigen Class on T Follicular Helper Cell Responses to Pneumococcal Polysaccharide-Protein Conjugate Vaccine-13.
    J Immunol. 2021 Apr 30. pii: jimmunol.2001133. doi: 10.4049/jimmunol.2001133.
    PubMed     Abstract available


  40. PRAKASH S, Srivastava R, Coulon PG, Dhanushkodi NR, et al
    Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.
    J Immunol. 2021 Apr 28. pii: jimmunol.2001438. doi: 10.4049/jimmunol.2001438.
    PubMed     Abstract available


  41. SHUTE T, Amiel E, Alam N, Yates JL, et al
    Glycolipid-Containing Nanoparticle Vaccine Engages Invariant NKT Cells to Enhance Humoral Protection against Systemic Bacterial Infection but Abrogates T-Independent Vaccine Responses.
    J Immunol. 2021;206:1806-1816.
    PubMed     Abstract available


  42. SANGEWAR N, Waghela SD, Yao J, Sang H, et al
    Novel Potent IFN-gamma-Inducing CD8(+) T Cell Epitopes Conserved among Diverse Bovine Viral Diarrhea Virus Strains.
    J Immunol. 2021;206:1709-1718.
    PubMed     Abstract available


    March 2021
  43. EACRET JS, Parzych EM, Gonzales DM, Burns JM Jr, et al
    Inclusion of an Optimized Plasmodium falciparum Merozoite Surface Protein 2-Based Antigen in a Trivalent, Multistage Malaria Vaccine.
    J Immunol. 2021 Mar 31. pii: jimmunol.2000927. doi: 10.4049/jimmunol.2000927.
    PubMed     Abstract available


  44. CHANDRA J, Teoh SM, Kuo P, Tolley L, et al
    Manganese-Doped Silica-Based Nanoparticles Promote the Efficacy of Antigen-Specific Immunotherapy.
    J Immunol. 2021;206:987-998.
    PubMed     Abstract available


    February 2021
  45. LAYTON ED, Barman S, Wilburn DB, Yu KKQ, et al
    T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette-Guerin Vaccination.
    J Immunol. 2021 Feb 3. pii: jimmunol.2001065. doi: 10.4049/jimmunol.2001065.
    PubMed     Abstract available


  46. HESSELL AJ, Li L, Malherbe DC, Barnette P, et al
    Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies Alone.
    J Immunol. 2021 Feb 3. pii: jimmunol.2001010. doi: 10.4049/jimmunol.2001010.
    PubMed     Abstract available


    January 2021
  47. SPENCER DA, Malherbe DC, Vazquez Bernat N, Adori M, et al
    Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.
    J Immunol. 2021 Jan 20. pii: jimmunol.2001082. doi: 10.4049/jimmunol.2001082.
    PubMed     Abstract available


  48. JOAG V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, et al
    Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
    J Immunol. 2021 Jan 13. pii: jimmunol.2001400. doi: 10.4049/jimmunol.2001400.
    PubMed     Abstract available


  49. AGGIO JB, Krmeska V, Ferguson BJ, Wowk PF, et al
    Vaccinia Virus Infection Inhibits Skin Dendritic Cell Migration to the Draining Lymph Node.
    J Immunol. 2021 Jan 8. pii: jimmunol.2000928. doi: 10.4049/jimmunol.2000928.
    PubMed     Abstract available


    December 2020
  50. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2020 Dec 16. pii: jimmunol.2001086. doi: 10.4049/jimmunol.2001086.
    PubMed     Abstract available


    November 2020
  51. BHATTACHARYA P, Dey R, Saxena A, Karmakar S, et al
    Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated Leishmania Vaccine.
    J Immunol. 2020 Nov 11. pii: jimmunol.2000829. doi: 10.4049/jimmunol.2000829.
    PubMed     Abstract available


    October 2020
  52. TSUJIMURA Y, Shiogama Y, Soma S, Okamura T, et al
    Vaccination with Intradermal Bacillus Calmette-Guerin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus Macaques.
    J Immunol. 2020 Oct 23. pii: jimmunol.2000386. doi: 10.4049/jimmunol.2000386.
    PubMed     Abstract available


    September 2020
  53. D'AGOSTINO MR, Lai R, Afkhami S, Khera A, et al
    Airway Macrophages Mediate Mucosal Vaccine-Induced Trained Innate Immunity against Mycobacterium tuberculosis in Early Stages of Infection.
    J Immunol. 2020 Sep 30. pii: jimmunol.2000532. doi: 10.4049/jimmunol.2000532.
    PubMed     Abstract available


    July 2020
  54. AHMED A, Akhade AS, Qadri A
    Accessibility of O Antigens Shared between Salmonella Serovars Determines Antibody-Mediated Cross-Protection.
    J Immunol. 2020;205:438-446.
    PubMed     Abstract available


  55. BOULOUIS C, Gorin JB, Dias J, Bergman P, et al
    Opsonization-Enhanced Antigen Presentation by MR1 Activates Rapid Polyfunctional MAIT Cell Responses Acting as an Effector Arm of Humoral Antibacterial Immunity.
    J Immunol. 2020;205:67-77.
    PubMed     Abstract available


    March 2020
  56. DANAHY DB, Berton RR, Badovinac VP
    Cutting Edge: Antitumor Immunity by Pathogen-Specific CD8 T Cells in the Absence of Cognate Antigen Recognition.
    J Immunol. 2020;204:1431-1435.
    PubMed     Abstract available


    February 2020
  57. GALKIN A, Chen Y, Guenaga J, O'Dell S, et al
    HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice.
    J Immunol. 2020 Feb 17. pii: jimmunol.1901051. doi: 10.4049/jimmunol.1901051.
    PubMed     Abstract available


    January 2020
  58. ALDON Y, Kratochvil S, Shattock RJ, McKay PF, et al
    Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae.
    J Immunol. 2020 Jan 8. pii: jimmunol.1901184. doi: 10.4049/jimmunol.1901184.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: